Skip to content

TTPHCC

TTPHCC — medical apps + ongoing tech partner

We design, build, and continuously evolve mobile medical applications for TTPHCC — a Jeddah-based healthcare communications group. From scoped delivery to becoming their long-term technical partner.

Sector
Healthcare communications
Year
2024
Services
Web & Mobile Apps · Tech Talent · DevOps & Cloud

TTPHCC (The Tipping Point Healthcare Communication) is a Jeddah-based joint venture of five healthcare-industry specialists building mobile platforms for medical reps, healthcare professionals, and pharma communications. They needed an engineering partner who could ship medical-grade mobile apps at the same pace as their product ideas — not just an agency that hands off and disappears.

What we built

  • VenetoStart, OncoStart, AdMove, and Immuno PL AI — production mobile applications in the medical communications space, each shipped end-to-end: design, Flutter (iOS + Android) builds, backend APIs, CI/CD, and post-launch operations.
  • Reusable scaffolding across the portfolio so each new app starts from a known-good architecture instead of a blank page — analytics, error monitoring, secure auth, and release plumbing live in shared modules.
  • Bilingual UX patterns (English / Arabic) baked into every app from the first sprint.

VenetoStart on iPhone — the indication picker offering CLL and AML with SPC and REF & ABB sections, beside the entry gate stating the app is an educational resource for licensed healthcare professionals in Egypt, with adverse-event and pharmacovigilance reporting addresses and Accept or Close

VenetoStart, published for AbbVie and live on both stores. Left, the picker that routes a clinician to chronic lymphocytic or acute myeloid leukaemia material. Right, the gate every session passes through: an attestation of Egyptian HCP licensure, with adverse-event reporting routes on the same screen. That gate is the constraint the whole build is shaped around — regulated content, versioned against a local label, with the reporting path never more than a tap away. The dosing schedules behind it are for licensed professionals, so they are not reproduced here.

Immuno PL AI on iPhone — the welcome screen explaining that AI-controlled avatars simulate real patient interactions so physicians can practise shared decision-making, beside a grid of six colour-coded risk-communication principles, each with a video

Immuno PL AI, shipped October 2025. Physicians rehearse difficult conversations against AI-controlled avatars, backed by a library of risk-communication principles drawn from published research. Note the material code and preparation date pinned to the bottom of the screen — every asset in pharma communications carries one, and the release process has to keep them accurate.

The partnership

After shipping the initial apps, TTPHCC promoted us to their ongoing technical partner — the highest engagement tier we offer. That means a dedicated senior squad embedded in their roadmap, continuous development, on-call coverage, and shared decision-making on architecture and product direction. It’s the model we like best: aligned incentives, long horizons, and the kind of trust that only forms after you’ve shipped something hard together.

My MDA Targets, in design — the entry screen of the prototype, with a disclaimer that the app is an educational scoring aid for healthcare professionals practising in the GCC, an intro video, an I accept button and an HCP-region confirmation

In design now: My MDA Targets, an educational scoring aid for healthcare professionals across the GCC. This is the prototype, not a shipped product — it is on this page because the partnership is current, not because the app is finished. It opens the way the whole portfolio does: a licensure gate, and a plain statement that a score supports clinical judgement rather than replacing it.

Let's build something your customers brag about.

Tell us where you are and where you want to go — we'll come back within one business day with an honest opinion and a path forward.